Could a daily millet porridge reshape your gut and tame metabolic syndrome?

NCT ID NCT07703371

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study investigates whether drinking a fiber-rich kodo millet porridge every day for 12 weeks can improve gut bacteria diversity and metabolic health in overweight or obese adults. Participants will consume a standardized porridge beverage while keeping their usual diet and activity. The goal is to see if this simple food supplement can help reduce risks like insulin resistance and high cholesterol.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a daily kodo millet porridge beverage rich in dietary fiber and polyphenols
What this could lead to
If it works, this could point toward a simple dietary supplement to improve gut health and reduce metabolic syndrome risk in overweight people.
What could go wrong
This is a small, early-stage trial with only 50 participants, so results may not apply broadly. The effect may be modest or hard to separate from other lifestyle factors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • JSS Medical College, JSS Academy of Higher Education & Research(JSSAHER).

    RECRUITING

    Mysore, Karnataka, 570 015, India

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.